| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 27,720 | $40 | $1.1M |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 5,580 | $20 | $122.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,240 | $100 | $121.1K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,090 | $40 | $117.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22,600 | $1 | $45.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $120 | $42.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 240 | $150 | $35.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 230 | $140 | $32.1K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 360 | $80 | $29.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $180 | $13.3K |